Assets/RVIR

DORRS MARKET INTELLIGENCE

Vir Biotechnology Reality

RVIREquityReality
Open terminal ↗
Token price—No pricing observation available
Token market capitalization—Token market cap not supplied
Circulating supply0DORRS issuer token data
Fully diluted valuation (FDV)$0DORRS issuer token data
Reported deployment value$0DORRS valuation basis

ASSET PROFILE

Business description

CDI CDI-7121458782

Vir Biotechnology is a U.S. clinical-stage immunology company developing antibody-based therapies for infectious diseases and cancer.

TRADING ACTIVITY

Last-sale transactions

Reported executions
↗

No last-sale activity to display

Executed transactions will appear here when reported by a connected source.